Company: PFSA
Filing Date: 2025-08-11
Form Type: S-1
Source: 0001213900-25-073872
Chunk: 278

Company: Profusa, Inc.
Filing Date: 2025-08-11
Form: S-1
Chunk 278
---
 $13,815 at March 31, 2025 and December 31, 2024)    |     |   |      13,701 |   |     |   |      13,701 |   |
| Series C/C-1 convertible preferred stock: $0.001 par value–8,907,893 shares authorized at March 31, 2025 and December 31, 2024, and 8,220,445 shares issued and outstanding at March 31, 2025 and December 31, 2024, (Liquidation preference $45,062 at March 31, 2025 and December 31, 2024) |     |   |      46,217 |   |     |   |      46,217 |   |
| Total convertible preferred stock                                                                                                                                                                                                                                                             |     |   |      65,149 |   |     |   |      65,149 |   |
| Stockholders’ deficit:                                                                                                                                                                                                                                                                        |     |   |             |   |     |   |             |   |
| Common stock: $0.0001 par value–40,000,000 authorized shares at March 31, 2025 and December 31, 2024, and 5,604,651 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively                                                                                       |     |   |           — |   |     |   |           — |   |
| Additional paid-in-capital                                                                                                                                                                                                                                                                    |     |   |       5,758 |   |     |   |       5,753 |   |
| Accumulated deficit                                                                                                                                                                                                                                                                           |     |   |    (127,674 | ) |     |   |    (124,958 | ) |
| Total stockholders’ deficit                                                                                                                                                                                                                                                                   |     |   |    (121,916 | ) |     |   |    (119,205 | ) |
| Total liabilities, convertible preferred stock and stockholders’ deficit                                                                                                                                                                                                                      |     | $ |       3,239 |   |     | $ |       3,073 |   |

The accompanying notes are an integral part of these condensed consolidated financial statements.

F-30

PROFUSA, INC. AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
(UNAUDITED)
(IN THOUSANDS, EXCEPT